Indication
Molluscum contagiosum
3 clinical trials
3 products
1 drug
Product
mRNA-1769Clinical trial
A Randomised, Placebo-Controlled, Dose-Ranging, Observer-Blind Phase 1/2 Study to Evaluate the Safety, Tolerability, and Immunogenicity of mRNA-1769 in Healthy ParticipantsStatus: Recruiting, Estimated PCD: 2025-05-30
Clinical trial
Break-through Infection Following Mpox vaccinatIon: Target Trial EmulationStatus: Completed, Estimated PCD: 2024-03-30
Product
Mpox VaccineClinical trial
A Phase III, Multi-country, Randomized, Placebo-controlled, Double-blinded Trial to Assess the Efficacy and Safety of Tecovirimat Antiviral Treatment for Patients With Monkeypox Virus DiseaseStatus: Recruiting, Estimated PCD: 2024-01-01
Product
TecovirimatDrug
Varlilumab